Stay connected to your highest-risk patients

Know the moment your patient is hospitalized — anywhere.

When a high-risk patient is admitted, the team that knows their case often finds out too late. DocFindMe notifies the treating clinician right away, so the people who know the patient can be reached before the next decision is made.

Open the app See the evidence
Care-team-only access · event-based, not location tracking

What the treating clinician sees the moment their patient is admitted

J.M.
Hospital encounter detected
AWAITING RESPONSE
1 CAR-T · Day +12 · DLBCL
2 Metro General Hospital
At hospital for 45 min
⚠ Required meds: Acyclovir, trimethoprim-sulfamethoxazole
3Call hospital — reach the inpatient team
Call patient
Call caregiver
Detected · Metro General Hospital · on-site
Awaiting patient responseThe patient has 2 minutes to confirm before the clinician is alerted automatically.
  • 1 Who the patient is: their therapy and how many days since treatment.
  • 2 Where and when: the hospital, and how long they've been on-site.
  • 3 What to do: one tap to reach the inpatient team caring for them.
Why DocFindMe exists

From our founder

One of my patients with a curable lymphoma, responding well to treatment, was unexpectedly admitted to an outside hospital for an unrelated condition. He was unable to communicate his history on arrival, and with no one present who knew his case, the inpatient team had no way to know his cancer was responding to treatment. Working with limited knowledge of his prognosis, they began moving toward comfort measures. Only by learning of his hospitalization incidentally was I able to reach his inpatient team and provide the clinical context that changed his hospital course.

The outcome was favorable, but it hinged on chance rather than a system designed to inform me, which is precisely the problem DocFindMe addresses.

— Dr. Utkarsh Acharya, oncologist & founder of DocFindMe

How the gap usually unfolds

01

Admitted elsewhere

A patient is hospitalized at a facility that can't see their treatment history.

02

No one is notified

The treating team isn't told. Sometimes the patient is too unwell to say who to call.

03

Decisions without context

The other team acts without knowing the therapy, the trajectory, or which medications can't be stopped.

04

Found late, or by chance

The treating team learns of it afterward, if at all.

DocFindMe replaces that coincidence with a notification.

What the literature shows

The gap is real, and it's measurable

DocFindMe addresses a documented problem: high-risk cancer patients are hospitalized often, those admissions are frequently acute, and care fragmentation is linked to worse outcomes.

73.5%
Cell therapy acuity

Among CAR-T patients' emergency visits, nearly all required urgent or emergent care and 73.5% led to admission; 30-day mortality after that first ED visit was 17%. An emergency visit in this population is rarely minor, and recognizing complications early is time-sensitive.

Lipe DN, et al. Front Oncol. 2023;13:1122329. doi:10.3389/fonc.2023.1122329 · PMID 37007139
1 in 5
Fragmented care

After major cancer surgery, about one in five 30-day readmissions occurred at a different hospital than where the patient was treated, and those carried higher in-hospital mortality (OR 1.31; 95% CI 1.03–1.66). Shown here for the underlying principle: being readmitted away from your team is dangerous.

Zheng C, et al. J Am Coll Surg. 2016;222(5):780–789. doi:10.1016/j.jamcollsurg.2016.01.052 · PMID 27016905
SAE
Trial integrity

A hospitalization meets the regulatory definition of a serious adverse event requiring expedited reporting. When a trial participant is admitted off-site and the investigator isn't notified, adverse-event capture and protocol oversight are at risk, an operational exposure for sponsors and sites.

FDA 21 CFR 312.32; ICH E6(R2). Adverse-event under-reporting in oncology trials: Children's Oncology Group report (PMC8940729).

These studies describe the clinical and operational problem DocFindMe is built to address. They are not measurements of DocFindMe's effect; the product has not yet been studied for outcomes. Figures are reported from the cited sources.

Who it's for

The patients where a missed call changes the outcome

DocFindMe is built for the patients a clinician worries about most, and for the moments when knowing early matters.

A fast-growing field: seven FDA-approved CAR-T therapies, plus the first TIL and TCR-T products, each carrying its own time-sensitive, post-treatment management nuances that an outside team may not recognize.
Source: FDA — Approved Cellular and Gene Therapy Products.
Cell therapy
CAR-T and related therapies, where time-sensitive complications may go unrecognized outside the treating center
Transplant
Autologous and allogeneic recipients, whose post-transplant complications depend on the treating team's context
Clinical-trial participants
Where an off-site admission can mean a missed adverse event or protocol deviation
Other high-risk patients
Any case where the treating team needs to know about an admission, especially somewhere they can't see
How it works

Three steps, then it runs quietly

No tracking dashboard to watch. DocFindMe stays silent until something happens.

01

Connect

The clinician adds the patient and shares an invite. The patient connects in a tap, with phone or Google sign-in and nothing to remember.

02

Detect

If the patient is at a hospital long enough, or taps the alert button, DocFindMe recognizes a hospital encounter. There's no constant location feed.

03

Reach the team

The treating clinician is notified with the patient's therapy, day post-infusion, and continuity-critical meds, and can call the inpatient team, patient, or caregiver directly.

Designed to be defensible

A notification tool, not surveillance

The most private design is the one that collects the least. DocFindMe is built around a single event, not a live map.

Event-based, not tracking

DocFindMe doesn't follow patients through their day. It responds to one thing: a sustained hospital visit, or a tap of the alert button. Between those, nothing is watched.

Care-team-only by design

A patient's information is visible to the clinicians they choose to connect with, and no one else. The patient controls the connection.

Encrypted, end to end

Information is encrypted in transit and at rest. Access is scoped to the people who need it, and every alert is logged.

Aggregate insight, de-identified

Beyond individual alerts, de-identified and aggregated patterns can show where and when these admissions happen, helping systems understand and close the gap.

DocFindMe is a physician-notification tool. It does not provide medical advice, medication instructions, or clinical guidance, and it is not a substitute for emergency services.

Get access

Open DocFindMe

For clinicians

Clinician App

Manage patients, review encounters, and respond to alerts.

Open the Clinician App →
For patients

Patient App

Connect your care team and confirm a hospital encounter in a tap.

Open the Patient App →
Built by clinicians

Made by the physicians who live this problem

DocFindMe was created by practicing oncologists and physicians who have seen firsthand what happens when a treating team isn't in the loop.

Utkarsh Acharya, DO, FACP
Founder
Associate Professor of Medicine, The Ohio State University
Columbus, OH
Christopher Lathan, MD
Co-Founder
Associate Professor of Medicine, Harvard Medical School
Boston, MA
Albert Woo, MD
Co-Founder
Founder, Boston Medical Data · Physician, Tufts Medical Center
Boston, MA

Institutional affiliations are listed for identification purposes only and do not imply institutional endorsement of DocFindMe.